scispace - formally typeset
Search or ask a question
Institution

American Cancer Society

NonprofitAtlanta, Georgia, United States
About: American Cancer Society is a nonprofit organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Cancer & Population. The organization has 1339 authors who have published 3700 publications receiving 688166 citations. The organization is also known as: American Cancer Society, ACS & American Society for the Control of Cancer.


Papers
More filters
Journal ArticleDOI
TL;DR: It is now estimated that fewer than 210,000 new cases of prostate cancer may be diagnosed in 1997 than previously estimated.
Abstract: Society estimated that 334,500 new cases of prostate cancer might occur in the United States during 1997.1 That projection was largely influenced by the rapid increase in incidence rates of prostate cancer during the late 1980s and early 1990s, but it also included a sharp decline between 1992 and 1993.2-5 Because recently available rates provided evidence of continued decline, a midyear adjustment to the 1997 projection was deemed necessary. We now estimate that fewer than 210,000 new cases of prostate cancer may be diagnosed in 1997.

115 citations

Journal Article
TL;DR: The findings are consistent with most previous studies that found no association between recreational physical activity and overall prostate cancer risk but suggest physical activity may be associated with reduced risk of aggressive prostate cancer.
Abstract: Physical activity has been proposed as a modifiable risk factor for prostate cancer because of its potential effects on circulating hormones such as testosterone and insulin. We examined the association of various measures of physical activity with prostate cancer risk among men in the American Cancer Society Cancer Prevention Study II Nutrition Cohort, a large prospective study of U.S. adults. Information on recreational physical activity was obtained from a self-administered questionnaire completed at cohort enrollment in 1992/1993, as well as from a questionnaire completed as part of an earlier study in 1982. During the 9-year prospective follow-up, 5,503 incident prostate cancer cases were identified among 72,174 men who were cancer-free at enrollment. Cox proportional hazards modeling was used to compute hazard rate ratios (RR) for measures of recreational physical activity and to adjust for potential confounding factors. We observed no difference in risk of prostate cancer between men who engaged in the highest level of recreational physical activity (>35 metabolic equivalent-hours/wk) and those who reported no recreational physical activity at baseline (RR, 0.90; 95% confidence interval, 0.78-1.04; P for trend = 0.31). We also did not observe an association between prostate cancer and recalled physical activity at age 40 or exercise reported in 1982. However, the incidence of aggressive prostate cancer was inversely associated with >35 metabolic equivalent-hours/wk of recreational physical activity compared with that in men who reported no recreational physical activity (RR, 0.69; 95% confidence interval, 0.52-0.92; P for trend = 0.06). Our findings are consistent with most previous studies that found no association between recreational physical activity and overall prostate cancer risk but suggest physical activity may be associated with reduced risk of aggressive prostate cancer.

115 citations

Journal ArticleDOI
Maggie C.Y. Ng1, Mariaelisa Graff2, Yingchang Lu3, Anne E. Justice2, Poorva Mudgal1, Ching-Ti Liu4, Kristin L. Young2, Lisa R. Yanek5, Mary F. Feitosa6, Mary K. Wojczynski6, Kristin A. Rand7, Jennifer A. Brody8, Brian E. Cade9, Latchezar Dimitrov1, Qing Duan2, Xiuqing Guo10, Leslie A. Lange2, Mike A. Nalls11, Hayrettin Okut1, Salman M. Tajuddin11, Bamidele O. Tayo12, Sailaja Vedantam13, Jonathan P. Bradfield14, Guanjie Chen11, Wei-Min Chen15, Alessandra Chesi14, Marguerite R. Irvin16, Badri Padhukasahasram17, Jennifer A. Smith18, Wei Zheng19, Matthew A. Allison20, Christine B. Ambrosone21, Elisa V. Bandera22, Traci M. Bartz8, Sonja I. Berndt, Leslie Bernstein23, William J. Blot, Erwin P. Bottinger3, John D. Carpten7, Stephen J. Chanock, Yii-Der Ida Chen10, David V. Conti7, Richard S. Cooper12, Myriam Fornage24, Barry I. Freedman1, Melissa E. Garcia11, Phyllis J. Goodman25, Yu-Han H. Hsu26, Yu-Han H. Hsu13, Yu-Han H. Hsu27, Jennifer J. Hu28, Chad D. Huff29, Sue A. Ingles7, Esther M. John30, Rick A. Kittles31, Eric A. Klein32, Jin Li33, Barbara McKnight8, Uma Nayak15, Barbara Nemesure34, Adesola Ogunniyi35, Andrew F. Olshan2, Michael F. Press7, Rebecca Rohde2, Benjamin A. Rybicki17, Babatunde L. Salako35, Maureen Sanderson36, Yaming Shao2, David S. Siscovick37, Janet L. Stanford25, Victoria L. Stevens38, Alex Stram7, Sara S. Strom29, Dhananjay Vaidya39, Dhananjay Vaidya5, John S. Witte40, Jie Yao10, Xiaofeng Zhu41, Regina G. Ziegler11, Alan B. Zonderman11, Adebowale Adeyemo11, Stefan Ambs, Mary Cushman42, Jessica D. Faul18, Hakon Hakonarson43, Hakon Hakonarson14, Albert M. Levin17, Katherine L. Nathanson43, Erin B. Ware18, David R. Weir18, Wei Zhao18, Degui Zhi24, Donna K. Arnett44, Struan F.A. Grant, Sharon L.R. Kardia18, Olufunmilayo I. Oloapde45, Dabeeru C. Rao6, Charles N. Rotimi11, Michèle M. Sale15, L. Keoki Williams17, Babette S. Zemel43, Diane M. Becker5, Ingrid B. Borecki6, Ingrid B. Borecki46, Michele K. Evans11, Tamara B. Harris11, Joel N. Hirschhorn26, Joel N. Hirschhorn27, Joel N. Hirschhorn13, Yun Li2, Sanjay R. Patel47, Bruce M. Psaty8, Jerome I. Rotter10, James G. Wilson48, Donald W. Bowden1, L. Adrienne Cupples11, L. Adrienne Cupples4, Christopher A. Haiman7, Ruth J. F. Loos3, Kari E. North2 
TL;DR: The results suggest that 1000 Genomes imputation showed modest improvement in identifying GWAS loci including low frequency variants, and trans-ethnic meta-analyses further improved fine mapping of putative causal variants in loci shared between the African and European ancestry populations.
Abstract: Genome-wide association studies (GWAS) have identified >300 loci associated with measures of adiposity including body mass index (BMI) and waist-to-hip ratio (adjusted for BMI, WHRadjBMI), but few have been identified through screening of the African ancestry genomes. We performed large scale meta-analyses and replications in up to 52,895 individuals for BMI and up to 23,095 individuals for WHRadjBMI from the African Ancestry Anthropometry Genetics Consortium (AAAGC) using 1000 Genomes phase 1 imputed GWAS to improve coverage of both common and low frequency variants in the low linkage disequilibrium African ancestry genomes. In the sex-combined analyses, we identified one novel locus (TCF7L2/HABP2) for WHRadjBMI and eight previously established loci at P < 5×10-8: seven for BMI, and one for WHRadjBMI in African ancestry individuals. An additional novel locus (SPRYD7/DLEU2) was identified for WHRadjBMI when combined with European GWAS. In the sex-stratified analyses, we identified three novel loci for BMI (INTS10/LPL and MLC1 in men, IRX4/IRX2 in women) and four for WHRadjBMI (SSX2IP, CASC8, PDE3B and ZDHHC1/HSD11B2 in women) in individuals of African ancestry or both African and European ancestry. For four of the novel variants, the minor allele frequency was low (<5%). In the trans-ethnic fine mapping of 47 BMI loci and 27 WHRadjBMI loci that were locus-wide significant (P < 0.05 adjusted for effective number of variants per locus) from the African ancestry sex-combined and sex-stratified analyses, 26 BMI loci and 17 WHRadjBMI loci contained ≤ 20 variants in the credible sets that jointly account for 99% posterior probability of driving the associations. The lead variants in 13 of these loci had a high probability of being causal. As compared to our previous HapMap imputed GWAS for BMI and WHRadjBMI including up to 71,412 and 27,350 African ancestry individuals, respectively, our results suggest that 1000 Genomes imputation showed modest improvement in identifying GWAS loci including low frequency variants. Trans-ethnic meta-analyses further improved fine mapping of putative causal variants in loci shared between the African and European ancestry populations.

115 citations

Journal ArticleDOI
TL;DR: It is suggested that high BMI, high WC, and type II diabetes mellitus are associated with higher risks of liver cancer and that the association may differ by status of viral hepatitis infection.
Abstract: Incidence rates for liver cancer have increased 3-fold since the mid-1970s in the United States in parallel with increasing trends for obesity and type II diabetes mellitus. We conducted an analysis of baseline body mass index (BMI), waist circumference (WC), and type II diabetes mellitus with risk of liver cancer. The Liver Cancer Pooling Project maintains harmonized data from 1.57 million adults enrolled in 14 U.S.-based prospective studies. Cox regression estimated HRs and 95% confidence intervals (CI) adjusted for age, sex, study center, alcohol, smoking, race, and BMI (for WC and type II diabetes mellitus). Stratified analyses assessed whether the BMI-liver cancer associations differed by hepatitis sera-positivity in nested analyses for a subset of cases (n = 220) and controls (n = 547). After enrollment, 2,162 incident liver cancer diagnoses were identified. BMI, per 5 kg/m2, was associated with higher risks of liver cancer, more so for men (HR = 1.38; 95% CI, 1.30-1.46) than women (HR = 1.25; 95% CI, 1.17-1.35; Pinteraction = 0.02). WC, per 5 cm, was associated with higher risks of liver cancer, approximately equally by sex (overall, HR = 1.08; 95% CI, 1.04-1.13). Type II diabetes mellitus was associated with higher risk of liver cancer (HR = 2.61; 95% CI, 2.34-2.91). In stratified analyses, there was a null association between BMI and liver cancer risk for participants who were sera-positive for hepatitis. This study suggests that high BMI, high WC, and type II diabetes mellitus are associated with higher risks of liver cancer and that the association may differ by status of viral hepatitis infection. Cancer Res; 76(20); 6076-83. ©2016 AACR.

115 citations

Journal ArticleDOI
TL;DR: An integrative model of behavior change is described that has been successful in changing behavior across a wide range of health conditions and holds promise for developing a rational public health approach to skin cancer prevention based on sound behavioral science.

115 citations


Authors

Showing all 1345 results

NameH-indexPapersCitations
Walter C. Willett3342399413322
Meir J. Stampfer2771414283776
Frank B. Hu2501675253464
David J. Hunter2131836207050
Edward Giovannucci2061671179875
Irving L. Weissman2011141172504
Bernard Rosner1901162147661
Susan E. Hankinson15178988297
Paolo Boffetta148145593876
Jeffrey A. Bluestone14351577080
Richard D. Smith140118079758
Garth D. Illingworth13750561793
Brian E. Henderson13771269921
Ahmedin Jemal132500380474
Michael J. Thun12939279051
Network Information
Related Institutions (5)
University of Texas MD Anderson Cancer Center
92.5K papers, 4.7M citations

89% related

Memorial Sloan Kettering Cancer Center
65.3K papers, 4.4M citations

89% related

Fred Hutchinson Cancer Research Center
30.9K papers, 2.2M citations

88% related

Mayo Clinic
169.5K papers, 8.1M citations

86% related

University of California, San Francisco
186.2K papers, 12M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202312
20228
2021202
2020239
2019222
2018194